Cargando…
An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial
AIMS: The aim of our study was to analyse the benefits of a 9 week hybrid comprehensive telerehabilitation (HCTR) programme in heart failure (HF) patients according to aetiology, as a subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial. METHODS AND RESULTS: Overall, 55...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006702/ https://www.ncbi.nlm.nih.gov/pubmed/33527740 http://dx.doi.org/10.1002/ehf2.13189 |
_version_ | 1783672359725563904 |
---|---|
author | Szalewska, Dominika Główczyńska, Renata Piotrowicz, Ryszard Kowalik, Ilona Pencina, Michael J. Opolski, Grzegorz Zaręba, Wojciech Banach, Maciej Orzechowski, Piotr Pluta, Sławomir Irzmański, Robert Kalarus, Zbigniew Piotrowicz, Ewa |
author_facet | Szalewska, Dominika Główczyńska, Renata Piotrowicz, Ryszard Kowalik, Ilona Pencina, Michael J. Opolski, Grzegorz Zaręba, Wojciech Banach, Maciej Orzechowski, Piotr Pluta, Sławomir Irzmański, Robert Kalarus, Zbigniew Piotrowicz, Ewa |
author_sort | Szalewska, Dominika |
collection | PubMed |
description | AIMS: The aim of our study was to analyse the benefits of a 9 week hybrid comprehensive telerehabilitation (HCTR) programme in heart failure (HF) patients according to aetiology, as a subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial. METHODS AND RESULTS: Overall, 555 (65.3%) patients with ischaemic (IS) and 295 (34.7%) patients with non‐ischaemic (NIS) HF aetiology were randomized. There were no differences between the effect of HCTR and usual care (UC) on the primary outcome of number of days alive and out of the hospital in 26 months from the time of randomization in either aetiology (Wilcoxon–Mann–Whitney test), and no heterogeneity of effect between the aetiologies was noted (van Elteren test, P = 0.746). In Cox proportional hazards regression analysis, treatment was not independently associated with the secondary outcomes. For all‐cause mortality, the adjusted hazard ratio for HCTR vs. UC was 0.90 (95% confidence interval, 0.54–1.51) in IS and 1.42 (95% confidence interval, 0.69–2.94) in NIS (P interaction = 0.316). Differences between HCTR and UC in terms of change in the 6 min walk test distance and cardiopulmonary exercise test time after 9 weeks reached statistical significance in the IS arm (P = 0.015 and P < 0.001, respectively), but not in the NIS arm; however, tests of heterogeneity indicated no statistically significant differences. CONCLUSIONS: The trial showed no difference between HCTR and UC in the primary outcome of percentage of days alive and out of the hospital for either IS or NIS aetiology. Moreover, the magnitude of changes in the clinical and functional statuses of the HF patients did not differ by aetiology. HCTR might have had beneficial effects on the 6 min walk test distance and cardiopulmonary exercise test time after 9 weeks in the IS patients; however, the effect was not statistically significantly different from that observed in the NIS patients. |
format | Online Article Text |
id | pubmed-8006702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80067022021-04-01 An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial Szalewska, Dominika Główczyńska, Renata Piotrowicz, Ryszard Kowalik, Ilona Pencina, Michael J. Opolski, Grzegorz Zaręba, Wojciech Banach, Maciej Orzechowski, Piotr Pluta, Sławomir Irzmański, Robert Kalarus, Zbigniew Piotrowicz, Ewa ESC Heart Fail Original Research Articles AIMS: The aim of our study was to analyse the benefits of a 9 week hybrid comprehensive telerehabilitation (HCTR) programme in heart failure (HF) patients according to aetiology, as a subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial. METHODS AND RESULTS: Overall, 555 (65.3%) patients with ischaemic (IS) and 295 (34.7%) patients with non‐ischaemic (NIS) HF aetiology were randomized. There were no differences between the effect of HCTR and usual care (UC) on the primary outcome of number of days alive and out of the hospital in 26 months from the time of randomization in either aetiology (Wilcoxon–Mann–Whitney test), and no heterogeneity of effect between the aetiologies was noted (van Elteren test, P = 0.746). In Cox proportional hazards regression analysis, treatment was not independently associated with the secondary outcomes. For all‐cause mortality, the adjusted hazard ratio for HCTR vs. UC was 0.90 (95% confidence interval, 0.54–1.51) in IS and 1.42 (95% confidence interval, 0.69–2.94) in NIS (P interaction = 0.316). Differences between HCTR and UC in terms of change in the 6 min walk test distance and cardiopulmonary exercise test time after 9 weeks reached statistical significance in the IS arm (P = 0.015 and P < 0.001, respectively), but not in the NIS arm; however, tests of heterogeneity indicated no statistically significant differences. CONCLUSIONS: The trial showed no difference between HCTR and UC in the primary outcome of percentage of days alive and out of the hospital for either IS or NIS aetiology. Moreover, the magnitude of changes in the clinical and functional statuses of the HF patients did not differ by aetiology. HCTR might have had beneficial effects on the 6 min walk test distance and cardiopulmonary exercise test time after 9 weeks in the IS patients; however, the effect was not statistically significantly different from that observed in the NIS patients. John Wiley and Sons Inc. 2021-02-01 /pmc/articles/PMC8006702/ /pubmed/33527740 http://dx.doi.org/10.1002/ehf2.13189 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Articles Szalewska, Dominika Główczyńska, Renata Piotrowicz, Ryszard Kowalik, Ilona Pencina, Michael J. Opolski, Grzegorz Zaręba, Wojciech Banach, Maciej Orzechowski, Piotr Pluta, Sławomir Irzmański, Robert Kalarus, Zbigniew Piotrowicz, Ewa An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial |
title | An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial |
title_full | An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial |
title_fullStr | An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial |
title_full_unstemmed | An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial |
title_short | An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial |
title_sort | aetiology‐based subanalysis of the telerehabilitation in heart failure patients (telereh‐hf) trial |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006702/ https://www.ncbi.nlm.nih.gov/pubmed/33527740 http://dx.doi.org/10.1002/ehf2.13189 |
work_keys_str_mv | AT szalewskadominika anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT głowczynskarenata anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT piotrowiczryszard anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT kowalikilona anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT pencinamichaelj anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT opolskigrzegorz anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT zarebawojciech anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT banachmaciej anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT orzechowskipiotr anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT plutasławomir anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT irzmanskirobert anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT kalaruszbigniew anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT piotrowiczewa anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT szalewskadominika aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT głowczynskarenata aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT piotrowiczryszard aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT kowalikilona aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT pencinamichaelj aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT opolskigrzegorz aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT zarebawojciech aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT banachmaciej aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT orzechowskipiotr aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT plutasławomir aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT irzmanskirobert aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT kalaruszbigniew aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial AT piotrowiczewa aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial |